XHKG2327
Market cap152mUSD
Dec 23, Last price
0.29HKD
1D
0.00%
1Q
43.56%
Jan 2017
-23.68%
Name
Meilleure Health International Industry Group Ltd
Chart & Performance
Profile
Meilleure Health International Industry Group Limited, an investment holding company, engages in industrial hemp, healthcare-related, trading, agency service, property investment and leasing, and property development businesses in Hong Kong, the People's Republic of China, and internationally. The company is involved in the trading of construction materials; development and sale of residential properties; property investment and leasing activities; and sale of healthcare-related products. It also provides real estate agency services; cannabidiol downstream product application services; health management services, including anti-aging, aesthetic medicine, and other health consulting; and healthcare related product sales agency services. The company was formerly known as U-Home Group Holdings Limited and changed its name to Meilleure Health International Industry Group Limited in March 2017. Meilleure Health International Industry Group Limited is headquartered in Admiralty, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2015‑03 | |
Income | ||||||||||
Revenues | 129,304 7.85% | 119,894 -52.62% | 253,031 -4.57% | |||||||
Cost of revenue | 90,550 | 88,822 | 194,764 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 38,754 | 31,072 | 58,267 | |||||||
NOPBT Margin | 29.97% | 25.92% | 23.03% | |||||||
Operating Taxes | 14,493 | 7,605 | 25,248 | |||||||
Tax Rate | 37.40% | 24.48% | 43.33% | |||||||
NOPAT | 24,261 | 23,467 | 33,019 | |||||||
Net income | 40,830 129.10% | 17,822 -70.46% | 60,323 -27.70% | |||||||
Dividends | (65,500) | |||||||||
Dividend yield | 6.61% | |||||||||
Proceeds from repurchase of equity | (335) | (37,017) | (40,678) | |||||||
BB yield | 0.03% | 3.05% | 1.99% | |||||||
Debt | ||||||||||
Debt current | 159,748 | 79,945 | 59,009 | |||||||
Long-term debt | 137,765 | 174,874 | 113,130 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 229 | 230 | 6,379 | |||||||
Net debt | 79,480 | (124,640) | (307,403) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (136,491) | 43,151 | (83,270) | |||||||
CAPEX | (827) | (1,052) | (6,516) | |||||||
Cash from investing activities | 53,718 | (134,758) | 161,564 | |||||||
Cash from financing activities | (18,897) | 41,932 | (38,220) | |||||||
FCF | (72,445) | (192,806) | 193,944 | |||||||
Balance | ||||||||||
Cash | 106,309 | 217,275 | 387,038 | |||||||
Long term investments | 111,724 | 162,184 | 92,504 | |||||||
Excess cash | 211,568 | 373,464 | 466,890 | |||||||
Stockholders' equity | 326,061 | 352,602 | 412,545 | |||||||
Invested Capital | 1,340,045 | 1,208,799 | 1,179,477 | |||||||
ROIC | 1.90% | 1.97% | 2.78% | |||||||
ROCE | 2.37% | 1.90% | 3.49% | |||||||
EV | ||||||||||
Common stock shares outstanding | 4,093,235 | 4,109,972 | 4,266,263 | |||||||
Price | 0.24 -17.97% | 0.30 -38.54% | 0.48 0.00% | |||||||
Market cap | 990,563 -18.30% | 1,212,442 -40.79% | 2,047,806 -0.13% | |||||||
EV | 1,070,209 | 1,098,107 | 1,743,006 | |||||||
EBITDA | 41,393 | 34,924 | 61,843 | |||||||
EV/EBITDA | 25.85 | 31.44 | 28.18 | |||||||
Interest | 11,408 | 11,447 | 8,385 | |||||||
Interest/NOPBT | 29.44% | 36.84% | 14.39% |